Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Nyctalopin ELISA Kit (AC3023)
Cat.#: ASET-1612
Specifications
Description Human Nyctalopin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Nyctalopin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.058 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1557 Human DTX1 ELISA Kit (AC2968) Quantitative inquiry ASET-1411 Human Plexin B1 ELISA Kit (AC2822) Quantitative inquiry ASET-1115 Human AVPR1B ELISA Kit (AC2526) Quantitative inquiry ASET-1831 Human SFRP1 ELISA Kit (AC3242) Quantitative inquiry ASET-1011 Rat PTN ELISA Kit (AC2422) Quantitative inquiry ASET-1152 Human GAPDH ELISA Kit (AC2563) Quantitative inquiry ASET-2509 Human Acetylcholinesterase ELISA Kit (AC3920) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry ASET-1022 Human Neurexin 1 ELISA Kit (AC2433) Quantitative inquiry ASET-1968 Mouse EGR3 ELISA Kit (AC3379) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket